文献

J-GLOBAL ID：201602249358904566   整理番号：16A1175503

IL-6とMCP-1の遺伝的多型は食道癌における化学放射線療法により発生する血小板数減少を予見する

IL-6 and MCP-1 genetic polymorphisms are predictive of decreased platelet counts caused by chemoradiotherapy in esophageal cancer

著者 (11件)： Fujita Kazuma (Department of Pharmacy, Akita University Hospital, Akita, Japan) ,  Motoyama Satoru (Department of Comprehensive Cancer Control, Akita University Graduate School of Medicine, Akita, Japan) ,  Motoyama Satoru (Department of General Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan) ,  Sato Yusuke (Department of General Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan) ,  Yoshino Kei (Department of General Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan) ,  Sasaki Tomohiko (Department of General Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan) ,  Liu Jiajia (Department of General Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan) ,  Niioka Takenori (Department of Pharmacy, Akita University Hospital, Akita, Japan) ,  Anbai Akira (Department of Radiology, Akita University Graduate School of Medicine, Akita, Japan) ,  Minamiya Yoshihiro (Department of General Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan) ,  Miura Masatomo (Department of Pharmacy, Akita University Hospital, Akita, Japan)
資料名： Esophagus (Web)  (Esophagus (Web))
巻： 13  号： 3  ページ： 264-269  発行年： 2016年 
JST資料番号： U0600A  ISSN： 1612-9059  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 背景 化学放射線療法(CRT)への食道癌の高感度で信頼性のマ...

シソーラス用語： ヒト ,...
準シソーラス用語： *食道癌

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1175503&from=J-GLOBAL&jstjournalNo=U0600A") }}

著者キーワード (6件)： Esophageal cancer ,  Chemoradiotherapy ,  Platelet count decreased ,  IL-6 ,  MCP-1 ,  Polymorphism

分類 (3件)： 腫ようの薬物療法  (GE03032C) ,  腫ようの放射線療法  (GE03034K) ,  消化器の腫よう  (GH04000D)

引用文献 (25件)：

• Chen MF, Yang YH, Lai CH, et al. Outcome of patients with esophageal cancer: a nationwide analysis. Ann Surg Oncol. 2013;20:3023-30.
• Kumagai K, Rouvelas I, Tsai JA, et al. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg. 2014;101:321-38.
• Motoyama S, Sugiyama T, Ueno Y, et al. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy. Ann Surg Oncol. 2006;13:1724-31.
• Hayashi K, Motoyama S, Sugiyama T, et al. REG Iα is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients. Ann Surg Oncol. 2008;15:1224-31.
• Yoshino K, Motoyama S, Koyota S, et al. Identification of insulin-like growth factor 2 mRNA-binding protein 3 as a radioresistance factor in squamous esophageal cancer cells. Dis Esophagus. 2014;27:479-84.

タイトルに関連する用語 (7件)： IL-6 ,  MCP-1 ,  遺伝的多型 ,  食道癌 ,  化学放射線療法 ,  血小板数 ,  予見